The role of toll-like receptors in acute and chronic lung inflammation

Journal of Inflammation

Volumn 7, Issue , 2010, Pages

  Lafferty, Erin I ^a   Qureshi, Salman T ^a   Schnare, Markus ^b  

^a MCGILL UNIVERSITY   (Canada)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18 RECEPTOR; LIGAND; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ASTHMA; CELL INFILTRATION; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE RESISTANCE; ENZYME ACTIVATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LUNG INFECTION; NONHUMAN; PATHOGENESIS; PNEUMONIA; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 78649335026     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-7-57     Document Type: Review

References (220)

1. Lung infection - a public health priority. JP Mizgerd, PLoS Med 2006 3 2 76 10.1371/journal.pmed.0030076 16401173
2. Acute lower respiratory tract infection. JP Mizgerd, N Engl J Med 2008 358 7 716 727 10.1056/NEJMra074111 18272895
3. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. VL Campodonico M Gadjeva C Paradis-Bleau A Uluer GB Pier, Trends Mol Med 2008 14 3 120 133 18262467
4. Regulation of immunological homeostasis in the respiratory tract. PG Holt DH Strickland ME Wikstrom FL Jahnsen, Nat Rev Immunol 2008 8 2 142 152 10.1038/nri2236 18204469
5. TLR signaling pathways. K Takeda S Akira, Semin Immunol 2004 16 1 3 9 10.1016/j.smim.2003.10.003 14751757
6. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. B Lemaitre E Nicolas L Michaut JM Reichhart JA Hoffmann, Cell 1996 86 6 973 983 10.1016/S0092-8674(00) 80172-5 8808632
7. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. R Medzhitov P Preston-Hurlburt E Kopp A Stadlen C Chen S Ghosh CA Janeway Jr, Mol Cell 1998 2 2 253 258 10.1016/S1097-2765(00)80136-7 9734363
8. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. A Poltorak X He I Smirnova MY Liu C Van Huffel X Du D Birdwell E Alejos M Silva C Galanos M Freudenberg P Ricciardi-Castagnoli B Layton B Beutler, Science 1998 282 5396 2085 2088 10.1126/science.282.5396.2085 9851930
9. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). ST Qureshi L Lariviere G Leveque S Clermont KJ Moore P Gros D Malo, J Exp Med 1999 189 4 615 625 10.1084/jem.189.4.615 9989976
10. Discrimination of bacterial lipoproteins by Toll-like receptor 6. O Takeuchi T Kawai PF Muhlradt M Morr JD Radolf A Zychlinsky K Takeda S Akira, Int Immunol 2001 13 7 933 940 10.1093/intimm/13.7.933 11431423
11. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. F Hayashi KD Smith A Ozinsky TR Hawn EC Yi DR Goodlett JK Eng S Akira DM Underhill A Aderem, Nature 2001 410 6832 1099 1103 10.1038/35074106 11323673
12. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. L Alexopoulou AC Holt R Medzhitov RA Flavell, Nature 2001 413 6857 732 738 10.1038/35099560 11607032
13. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. SS Diebold T Kaisho H Hemmi S Akira C Reis e Sousa, Science 2004 303 5663 1529 1531 10.1126/science.1093616 14976261 (Pubitemid 38314425)
14. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. F Heil H Hemmi H Hochrein F Ampenberger C Kirschning S Akira G Lipford H Wagner S Bauer, Science 2004 303 5663 1526 1529 10.1126/science. 1093620 14976262
15. Endogenous ligands of TLR2 and TLR4: agonists or assistants? C Erridge, J Leukoc Biol 2010 87 6 989 999 10.1189/jlb.1209775 20179153
16. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. C Termeer F Benedix J Sleeman C Fieber U Voith T Ahrens K Miyake M Freudenberg C Galanos JC Simon, J Exp Med 2002 195 1 99 111 10.1084/jem.20001858 11781369
17. Endogenous ligands of Toll-like receptors. MF Tsan B Gao, J Leukoc Biol 2004 76 3 514 519 10.1189/jlb.0304127 15178705
18. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. V Urbonaviciute BG Furnrohr S Meister L Munoz P Heyder F De Marchis ME Bianchi C Kirschning H Wagner AA Manfredi JR Kalden G Schett P Rovere-Querini M Herrmann RE Voll, J Exp Med 2008 205 13 3007 3018 10.1084/jem.20081165 19064698
19. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. M Yamamoto S Sato K Mori K Hoshino O Takeuchi K Takeda S Akira, J Immunol 2002 169 12 6668 6672 12471095
20. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. M Carty R Goodbody M Schroder J Stack PN Moynagh AG Bowie, Nat Immunol 2006 7 10 1074 1081 10.1038/ni1382 16964262
21. A cell biological view of Toll-like receptor function: regulation through compartmentalization. GM Barton JC Kagan, Nat Rev Immunol 2009 9 8 535 542 10.1038/nri2587 19556980
22. TLR signaling. T Kawai S Akira, Semin Immunol 2007 19 1 24 32 10.1016/j.smim.2006.12.004 17275323
23. Signaling pathways downstream of pattern-recognition receptors and their cross talk. MS Lee YJ Kim, Annu Rev Biochem 2007 76 447 480 10.1146/annurev. biochem.76.060605.122847 17328678
24. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. LA O'Neill AG Bowie, Nat Rev Immunol 2007 7 5 353 364 10.1038/nri2079 17457343
25. Targeting signal transduction as a strategy to treat inflammatory diseases. LA O'Neill, Nat Rev Drug Discov 2006 5 7 549 563 10.1038/nrd2070 16773072
26. Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. KI Iwami T Matsuguchi A Masuda T Kikuchi T Musikacharoen Y Yoshikai, J Immunol 2000 165 12 6682 6686 11120784
27. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. JC Deng G Cheng MW Newstead X Zeng K Kobayashi RA Flavell TJ Standiford, J Clin Invest 2006 116 9 2532 2542 16917541
28. IRAK-M is a negative regulator of Toll-like receptor signaling. K Kobayashi LD Hernandez JE Galan CA Janeway Jr R Medzhitov RA Flavell, Cell 2002 110 2 191 202 10.1016/S0092-8674(02)00827-9 12150927
29. Negative regulation of toll-like receptor-mediated signaling by Tollip. G Zhang S Ghosh, J Biol Chem 2002 277 9 7059 7065 10.1074/jbc.M109537200 11751856
30. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. K Burns S Janssens B Brissoni N Olivos R Beyaert J Tschopp, J Exp Med 2003 197 2 263 268 10.1084/jem.20021790 12538665
31. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. A Mansell R Smith SL Doyle P Gray JE Fenner PJ Crack SE Nicholson DJ Hilton LA O'Neill PJ Hertzog, Nat Immunol 2006 7 2 148 155 10.1038/ni1299 16415872
32. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. C Dostert V Petrilli R Van Bruggen C Steele BT Mossman J Tschopp, Science 2008 320 5876 674 677 10.1126/science.1156995 18403674
33. Pattern recognition receptors and inflammation. O Takeuchi S Akira, Cell 2010 140 6 805 820 10.1016/j.cell.2010.01.022 20303872
34. Activation of airway epithelial cells by toll-like receptor agonists. Q Sha AQ Truong-Tran JR Plitt LA Beck RP Schleimer, Am J Respir Cell Mol Biol 2004 31 3 358 364 10.1165/rcmb.2003-0388OC 15191912
35. Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages. J Hoppstadter B Diesel R Zarbock T Breinig D Monz M Koch A Meyerhans L Gortner CM Lehr H Huwer AK Kiemer, Respir Res 2010 11 124 10.1186/1465-9921-11-124 20843333
36. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. NA Maris MC Dessing AF de Vos P Bresser JS van der Zee HM Jansen CA Spek T van der Poll, Eur Respir J 2006 28 3 622 626 10.1183/09031936.06. 00010806 16946093
37. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. G Andonegui CS Bonder F Green SC Mullaly L Zbytnuik E Raharjo P Kubes, J Clin Invest 2003 111 7 1011 1020 12671050
38. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. B Koller M Kappler P Latzin A Gaggar M Schreiner S Takyar M Kormann M Kabesch D Roos M Griese D Hartl, J Immunol 2008 181 4 2753 2763 18684966
39. Division of labor between dendritic cell subsets of the lung. CH GeurtsvanKessel BN Lambrecht, Mucosal Immunol 2008 1 6 442 450 10.1038/mi.2008.39 19079211
40. Mouse respiratory tract dendritic cell subsets and the immunological fate of inhaled antigens. ME Wikstrom PA Stumbles, Immunol Cell Biol 2007 85 3 182 188 17262055
41. Origin and functional specializations of DC subsets in the lung. M Plantinga H Hammad BN Lambrecht, Eur J Immunol 2010 40 8 2112 2118 10.1002/eji.201040562 20853496
42. Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes. GE Morris MK Whyte GF Martin PJ Jose SK Dower I Sabroe, Am J Respir Crit Care Med 2005 171 8 814 822 10.1164/rccm.200403-406OC 15657467
43. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Y Imai K Kuba GG Neely R Yaghubian-Malhami T Perkmann G van Loo M Ermolaeva R Veldhuizen YH Leung H Wang H Liu Y Sun M Pasparakis M Kopf C Mech S Bavari JS Peiris AS Slutsky S Akira M Hultqvist R Holmdahl J Nicholls C Jiang CJ Binder JM Penninger, Cell 2008 133 2 235 249 10.1016/j.cell.2008.02.043 18423196
44. Incidence and outcomes of acute lung injury. GD Rubenfeld E Caldwell E Peabody J Weaver DP Martin M Neff EJ Stern LD Hudson, N Engl J Med 2005 353 16 1685 1693 10.1056/NEJMoa050333 16236739
45. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. AA Beg, Trends Immunol 2002 23 11 509 512 10.1016/S1471-4906(02)02317-7 12401394
46. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. GB Johnson GJ Brunn Y Kodaira JL Platt, J Immunol 2002 168 10 5233 5239 11994480
47. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. JS Park D Svetkauskaite Q He JY Kim D Strassheim A Ishizaka E Abraham, J Biol Chem 2004 279 9 7370 7377 10.1074/jbc.M306793200 14660645
48. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. ST Smiley JA King WW Hancock, J Immunol 2001 167 5 2887 2894 11509636
49. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. A Tsung R Sahai H Tanaka A Nakao MP Fink MT Lotze H Yang J Li KJ Tracey DA Geller TR Billiar, J Exp Med 2005 201 7 1135 1143 10.1084/jem.20042614 15795240
50. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. RM Vabulas P Ahmad-Nejad S Ghose CJ Kirschning RD Issels H Wagner, J Biol Chem 2002 277 17 15107 15112 10.1074/jbc.M111204200 11842086
51. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Y Jiang J Xu C Zhou Z Wu S Zhong J Liu W Luo T Chen Q Qin P Deng, Am J Respir Crit Care Med 2005 171 8 850 857 10.1164/rccm.200407-857OC 15657466 (Pubitemid 40575712)
52. Early events in the recognition of danger signals after tissue injury. DJ Kaczorowski KP Mollen R Edmonds TR Billiar, J Leukoc Biol 2008 83 3 546 552 10.1189/jlb.0607374 18032691
53. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. IR Rifkin EA Leadbetter L Busconi G Viglianti A Marshak-Rothstein, Immunol Rev 2005 204 27 42 10.1111/j.0105-2896.2005.00239.x 15790348 (Pubitemid 40460491)
54. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. KR Taylor JM Trowbridge JA Rudisill CC Termeer JC Simon RL Gallo, J Biol Chem 2004 279 17 17079 17084 10.1074/jbc.M310859200 14764599
55. Pattern recognition receptor-dependent mechanisms of acute lung injury. M Xiang J Fan, Mol Med 2010 16 1-2 69 82 10.2119/molmed.2009.00097 19949486
56. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. M Yu H Wang A Ding DT Golenbock E Latz CJ Czura MJ Fenton KJ Tracey H Yang, Shock 2006 26 2 174 179 10.1097/01.shk.0000225404.51320.82 16878026
57. Innate immune recognition in infectious and noninfectious diseases of the lung. B Opitz V van Laak J Eitel N Suttorp, Am J Respir Crit Care Med 2010 181 12 1294 1309 10.1164/rccm.200909-1427SO 20167850
58. The role of Toll-like receptor 4 in environmental airway injury in mice. JW Hollingsworth DN Cook DM Brass JK Walker DL Morgan WM Foster DA Schwartz, Am J Respir Crit Care Med 2004 170 2 126 132 10.1164/rccm.200311-1499OC 15020293
59. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. J Fan A Kapus YH Li S Rizoli JC Marshall OD Rotstein, Am J Respir Cell Mol Biol 2000 22 4 412 421 10745022
60. Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. J Fan Y Li Y Vodovotz TR Billiar MA Wilson, Am J Physiol Lung Cell Mol Physiol 2006 290 4 738 L746 10.1152/ajplung.00280.2005 16272176
61. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Fan JC Marshall M Jimenez PN Shek J Zagorski OD Rotstein, J Immunol 1998 161 1 440 447 9647254
62. TLR Cross-Talk Mechanism of Hemorrhagic Shock-Primed Pulmonary Neutrophil Infiltration. J Fan, Open Crit Care Med J 2010 2 1 8 10.2174/ 1874828700902010001 20072711
63. Toll-like receptor 2 participates in the response to lung injury in a murine model of pulmonary contusion. JJ Hoth WP Hudson NA Brownlee BK Yoza EM Hiltbold JW Meredith CE McCall, Shock 2007 28 4 447 452 10.1097/shk. 0b013e318048801a 17558351
64. Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. Y Li M Xiang Y Yuan G Xiao J Zhang Y Jiang Y Vodovotz TR Billiar MA Wilson J Fan, Am J Physiol Regul Integr Comp Physiol 2009 297 6 1670 1680 19828841
65. Toll-like receptor 4-dependent responses to lung injury in a murine model of pulmonary contusion. JJ Hoth JD Wells NA Brownlee EM Hiltbold JW Meredith CE McCall BK Yoza, Shock 2009 31 4 376 381 10.1097/SHK.0b013e3181862279 18665044
66. Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. LJ Buccellato M Tso OI Akinci NS Chandel GR Budinger, J Biol Chem 2004 279 8 6753 6760 10.1074/jbc.M310145200 14625274
67. Science review: mechanisms of ventilator-induced injury. JA Frank MA Matthay, Crit Care 2003 7 3 233 241 10.1186/cc1829 12793874
68. Exogenous surfactant reduces ventilator-induced decompartmentalization of tumor necrosis factor alpha in absence of positive end-expiratory pressure. JJ Haitsma S Uhlig U Lachmann SJ Verbrugge DL Poelma B Lachmann, Intensive Care Med 2002 28 8 1131 1137 10.1007/s00134-002-1377-4 12185437
69. Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA. LN Tremblay D Miatto Q Hamid A Govindarajan AS Slutsky, Crit Care Med 2002 30 8 1693 1700 10.1097/00003246-200208000-00003 12163778
70. Low-tidal-volume mechanical ventilation induces a toll-like receptor 4-dependent inflammatory response in healthy mice. M Vaneker LA Joosten LM Heunks DG Snijdelaar FJ Halbertsma J van Egmond MG Netea JG van der Hoeven GJ Scheffer, Anesthesiology 2008 109 3 465 472 10.1097/ALN.0b013e318182aef1 18719444
71. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. X Zhang P Shan S Qureshi R Homer R Medzhitov PW Noble PJ Lee, J Immunol 2005 175 8 4834 4838 16210584
72. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. D Jiang J Liang J Fan S Yu S Chen Y Luo GD Prestwich MM Mascarenhas HG Garg DA Quinn RJ Homer DR Goldstein R Bucala PJ Lee R Medzhitov PW Noble, Nat Med 2005 11 11 1173 1179 10.1038/nm1315 16244651
73. Pulmonary surfactant: functions, abnormalities and therapeutic options. I Frerking A Gunther W Seeger U Pison, Intensive Care Med 2001 27 11 1699 1717 10.1007/s00134-001-1121-5 11810113
74. The future of surfactant therapy during ALI/ARDS. JF Lewis RA Veldhuizen, Semin Respir Crit Care Med 2006 27 4 377 388 10.1055/s-2006-948291 16909371
75. Deleterious role of TLR3 during hyperoxia-induced acute lung injury. LA Murray DA Knight L McAlonan R Argentieri A Joshi F Shaheen M Cunningham L Alexopolou RA Flavell RT Sarisky CM Hogaboam, Am J Respir Crit Care Med 2008 178 12 1227 1237 10.1164/rccm.200807-1020OC 18849495
76. Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. RM Burger J Peisach SB Horwitz, J Biol Chem 1981 256 22 11636 11644 6170635
77. The pathogenesis of bloemycin-induced pulmonary fibrosis in mice. IY Adamson DH Bowden, Am J Pathol 1974 77 2 185 197 4141224
78. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. CM McKee MB Penno M Cowman MD Burdick RM Strieter C Bao PW Noble, J Clin Invest 1996 98 10 2403 2413 10.1172/JCI119054 8941660
79. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. PW Noble CM McKee M Cowman HS Shin, J Exp Med 1996 183 5 2373 2378 10.1084/jem.183.5.2373 8642348
80. The role of Toll-like receptors in non-infectious lung injury. D Jiang J Liang Y Li PW Noble, Cell Res 2006 16 8 693 701 10.1038/sj.cr.7310085 16894359
81. The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment. MA Matthay RL Zemans, Annu Rev Pathol 2010 20936936
82. Newly recognized causes of acute lung injury: transfusion of blood products, severe acute respiratory syndrome, and avian influenza. MR Looney, Clin Chest Med 2006 27 4 591 600 abstract viii 10.1016/j.ccm.2006.06.004 17085248
83. Critically ill patients with severe acute respiratory syndrome. RA Fowler SE Lapinsky D Hallett AS Detsky WJ Sibbald AS Slutsky TE Stewart, JAMA 2003 290 3 367 373 10.1001/jama.290.3.367 12865378
84. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. TW Lew TK Kwek D Tai A Earnest S Loo K Singh KM Kwan Y Chan CF Yim SL Bek AC Kor WS Yap YR Chelliah YC Lai SK Goh, JAMA 2003 290 3 374 380 10.1001/jama.290.3.374 12865379 (Pubitemid 37430524)
85. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. TJ Franks PY Chong P Chui JR Galvin RM Lourens AH Reid E Selbs CP McEvoy CD Hayden J Fukuoka JK Taubenberger WD Travis, Hum Pathol 2003 34 8 743 748 10.1016/S0046-8177(03)00367-8 14506633
86. Animal models and vaccines for SARS-CoV infection. A Roberts EW Lamirande L Vogel JP Jackson CD Paddock J Guarner SR Zaki T Sheahan R Baric K Subbarao, Virus Res 2008 133 1 20 32 10.1016/j.virusres.2007.03.025 17499378
87. Toll-like receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible C3H mice. A Khanolkar SM Hartwig BA Haag DK Meyerholz JT Harty SM Varga, J Virol 2009 83 17 8946 8956 10.1128/JVI.01857-08 19553337
88. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. T Sheahan TE Morrison W Funkhouser S Uematsu S Akira RS Baric MT Heise, PLoS Pathog 2008 4 12 1000240 10.1371/journal.ppat.1000240 19079579
89. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. L Cervantes-Barragan R Zust F Weber M Spiegel KS Lang S Akira V Thiel B Ludewig, Blood 2007 109 3 1131 1137 10.1182/blood-2006-05-023770 16985170
90. Avian flu: influenza virus receptors in the human airway. K Shinya M Ebina S Yamada M Ono N Kasai Y Kawaoka, Nature 2006 440 7083 435 436 10.1038/440435a 16554799
91. H5N1 Virus Attachment to Lower Respiratory Tract. D van Riel VJ Munster E de Wit GF Rimmelzwaan RA Fouchier AD Osterhaus T Kuiken, Science 2006 312 5772 399 10.1126/science.1125548 16556800
92. Pulmonary fibrosis induced by H5N1 viral infection in mice. J Qiao M Zhang J Bi X Wang G Deng G He Z Luan N Lv T Xu L Zhao, Respir Res 2009 10 1 107 10.1186/1465-9921-10-107 19909524
93. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. T Xu J Qiao L Zhao G Wang G He K Li Y Tian M Gao J Wang H Wang C Dong, Am J Respir Crit Care Med 2006 174 9 1011 1017 10.1164/rccm.200511-1751OC 16917113
94. Recognition of single-stranded RNA viruses by Toll-like receptor 7. JM Lund L Alexopoulou A Sato M Karow NC Adams NW Gale A Iwasaki RA Flavell, Proc Natl Acad Sci USA 2004 101 15 5598 5603 10.1073/pnas.0400937101 15034168
95. Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. S Koyama KJ Ishii H Kumar T Tanimoto C Coban S Uematsu T Kawai S Akira, J Immunol 2007 179 7 4711 4720 17878370
96. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. AK Heer A Shamshiev A Donda S Uematsu S Akira M Kopf BJ Marsland, J Immunol 2007 178 4 2182 2191 17277123
97. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. A Pichlmair O Schulz CP Tan TI Naslund P Liljestrom F Weber C Reis e Sousa, Science 2006 314 5801 997 1001 10.1126/science.1132998 17038589
98. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. F Weber V Wagner SB Rasmussen R Hartmann SR Paludan, J Virol 2006 80 10 5059 5064 10.1128/JVI.80.10.5059-5064.2006 16641297
99. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. BL Jacobs JO Langland, Virology 1996 219 2 339 349 10.1006/viro.1996.0259 8638399
100. Defective interfering particles with covalently linked [+/-]RNA induce interferon. PI Marcus MJ Sekellick, Nature 1977 266 5605 815 819 10.1038/266815a0 194158
101. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. L Guillot R Le Goffic S Bloch N Escriou S Akira M Chignard M Si-Tahar, J Biol Chem 2005 280 7 5571 5580 10.1074/jbc.M410592200 15579900
102. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. R Le Goffic V Balloy M Lagranderie L Alexopoulou N Escriou R Flavell M Chignard M Si-Tahar, PLoS Pathog 2006 2 6 53 10.1371/journal.ppat.0020053 16789835
103. Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. R Le Goffic J Pothlichet D Vitour T Fujita E Meurs M Chignard M Si-Tahar, J Immunol 2007 178 6 3368 3372 17339430
104. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. IC Allen MA Scull CB Moore EK Holl E McElvania-TeKippe DJ Taxman EH Guthrie RJ Pickles JP Ting, Immunity 2009 30 4 556 565 10.1016/j.immuni.2009.02.005 19362020
105. Inflammasome recognition of influenza virus is essential for adaptive immune responses. T Ichinohe HK Lee Y Ogura R Flavell A Iwasaki, J Exp Med 2009 206 1 79 87 10.1084/jem.20081667 19139171
106. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. J Rehwinkel CP Tan D Goubau O Schulz A Pichlmair K Bier N Robb F Vreede W Barclay E Fodor C Reis e Sousa, Cell 2010 140 3 397 408 10.1016/j.cell.2010.01.020 20144762
107. Activation of innate immune antiviral responses by Nod2. A Sabbah TH Chang R Harnack V Frohlich K Tominaga PH Dube Y Xiang S Bose, Nat Immunol 2009 10 10 1073 1080 10.1038/ni.1782 19701189
108. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. PG Thomas P Dash JR Aldridge Jr AH Ellebedy C Reynolds AJ Funk WJ Martin M Lamkanfi RJ Webby KL Boyd PC Doherty TD Kanneganti, Immunity 2009 30 4 566 575 10.1016/j.immuni.2009.02. 006 19362023
109. Cystic fibrosis. PB Davis M Drumm MW Konstan, Am J Respir Crit Care Med 1996 154 5 1229 1256 8912731
110. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. K Faure T Sawa T Ajayi J Fujimoto K Moriyama N Shime JP Wiener-Kronish, Respir Res 2004 5 1 10.1186/1465-9921-5-1 15040820
111. Pathophysiology and management of pulmonary infections in cystic fibrosis. RL Gibson JL Burns BW Ramsey, Am J Respir Crit Care Med 2003 168 8 918 951 10.1164/rccm.200304-505SO 14555458
112. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. CM Greene TP Carroll SG Smith CC Taggart J Devaney S Griffin SJ O'Neill NG McElvaney, J Immunol 2005 174 3 1638 1646 15661927
113. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease. CJ Blohmke RE Victor AF Hirschfeld IM Elias DG Hancock CR Lane AG Davidson PG Wilcox KD Smith J Overhage RE Hancock SE Turvey, J Immunol 2008 180 11 7764 7773 18490781
114. Role of Toll-like receptor 5 in the innate immune response to acute P. aeruginosa pneumonia. AE Morris HD Liggitt TR Hawn SJ Skerrett, Am J Physiol Lung Cell Mol Physiol 2009 297 6 1112 1119 10.1152/ajplung.00155.2009 19801452
115. Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs. S Epelman D Stack C Bell E Wong GG Neely S Krutzik K Miyake P Kubes LD Zbytnuik LL Ma X Xie DE Woods CH Mody, J Immunol 2004 173 3 2031 2040 15265938
116. Human Toll-like receptor 4 recognizes host-specific LPS modifications. AM Hajjar RK Ernst JH Tsai CB Wilson SI Miller, Nat Immunol 2002 3 4 354 359 10.1038/ni777 11912497
117. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Z Zhang JP Louboutin DJ Weiner JB Goldberg JM Wilson, Infect Immun 2005 73 11 7151 7160 10.1128/IAI.73.11. 7151-7160.2005 16239509
118. The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. V Balloy A Verma S Kuravi M Si-Tahar M Chignard R Ramphal, J Infect Dis 2007 196 2 289 296 10.1086/518610 17570117
119. The myeloid differentiation factor 88 is dispensable for the development of a delayed host response to Pseudomonas aeruginosa lung infection in mice. MR Power JS Marshall M Yamamoto S Akira TJ Lin, Clin Exp Immunol 2006 146 2 323 329 10.1111/j.1365-2249.2006.03210.x 17034585
120. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. MR Power Y Peng E Maydanski JS Marshall TJ Lin, J Biol Chem 2004 279 47 49315 49322 10.1074/jbc.M402111200 15375173
121. TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections. R Ramphal V Balloy M Huerre M Si-Tahar M Chignard, J Immunol 2005 175 6 3927 3934 16148139
122. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. SJ Skerrett HD Liggitt AM Hajjar CB Wilson, J Immunol 2004 172 6 3377 3381 15004134
123. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. SJ Skerrett CB Wilson HD Liggitt AM Hajjar, Am J Physiol Lung Cell Mol Physiol 2007 292 1 312 322 10.1152/ajplung.00250.2006 16936244
124. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. R Ramphal V Balloy J Jyot A Verma M Si-Tahar M Chignard, J Immunol 2008 181 1 586 592 18566425
125. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. E Raoust V Balloy I Garcia-Verdugo L Touqui R Ramphal M Chignard, PLoS One 2009 4 10 7259 10.1371/journal.pone.0007259 19806220
126. The multifarious, multireplicon Burkholderia cepacia complex. E Mahenthiralingam TA Urban JB Goldberg, Nat Rev Microbiol 2005 3 2 144 156 10.1038/nrmicro1085 15643431 (Pubitemid 40207595)
127. Advances in Burkholderia cepacia complex. DP Speert, Paediatr Respir Rev 2002 3 3 230 235 10.1016/S1526-0542(02)00185-9 12376059
128. TLR 5, but neither TLR2 nor TLR4, is involved in lung epithelial cell response to Burkholderia cenocepacia. GM de C Ventura R Le Goffic V Balloy MC Plotkowski M Chignard M Si-Tahar, FEMS Immunol Med Microbiol 2008 54 1 37 44 10.1111/j.1574-695X.2008.00453.x 18680520
129. Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. TA Urban A Griffith AM Torok ME Smolkin JL Burns JB Goldberg, Infect Immun 2004 72 9 5126 5134 10.1128/IAI.72.9.5126-5134.2004 15322006
130. Lack of MyD88 protects the immunodeficient host against fatal lung inflammation triggered by the opportunistic bacteria Burkholderia cenocepacia. GM Ventura V Balloy R Ramphal H Khun M Huerre B Ryffel MC Plotkowski M Chignard M Si-Tahar, J Immunol 2009 183 1 670 676 10.4049/jimmunol.0801497 19535624
131. Chronic obstructive pulmonary disease: current burden and future projections. AD Lopez K Shibuya C Rao CD Mathers AL Hansell LS Held V Schmid S Buist, Eur Respir J 2006 27 2 397 412 10.1183/09031936.06.00025805 16452599
132. New paradigms in the pathogenesis of chronic obstructive pulmonary disease II. S Sethi P Mallia SL Johnston, Proc Am Thorac Soc 2009 6 6 532 534 10.1513/pats.200905-025DS 19741263
133. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. S Sethi TF Murphy, N Engl J Med 2008 359 22 2355 2365 10.1056/NEJMra0800353 19038881
134. Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"? RP Schleimer, Proc Am Thorac Soc 2005 2 4 342 346 discussion 371-342 10.1513/pats.200504-030SR 16267360
135. Toll-like receptor 4 deficiency causes pulmonary emphysema. X Zhang P Shan G Jiang L Cohn PJ Lee, J Clin Invest 2006 116 11 3050 3059 10.1172/JCI28139 17053835
136. Immunologic aspects of chronic obstructive pulmonary disease. MG Cosio M Saetta A Agusti, N Engl J Med 2009 360 23 2445 2454 10.1056/NEJMra0804752 19494220
137. Effects of cigarette smoke on the immune system. M Sopori, Nat Rev Immunol 2002 2 5 372 377 10.1038/nri803 12033743
138. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. E Doz N Noulin E Boichot I Guenon L Fick M Le Bert V Lagente B Ryffel B Schnyder VF Quesniaux I Couillin, J Immunol 2008 180 2 1169 1178 18178857
139. Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. T Maes KR Bracke KY Vermaelen IK Demedts GF Joos RA Pauwels GG Brusselle, Int Arch Allergy Immunol 2006 141 4 354 368 10.1159/000095462 16940747
140. The development of emphysema in cigarette smoke-exposed mice is strain dependent. A Guerassimov Y Hoshino Y Takubo A Turcotte M Yamamoto H Ghezzo A Triantafillopoulos K Whittaker JR Hoidal MG Cosio, Am J Respir Crit Care Med 2004 170 9 974 980 10.1164/rccm.200309-1270OC 15282203
141. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. D Droemann T Goldmann T Tiedje P Zabel K Dalhoff B Schaaf, Respir Res 2005 6 68 10.1186/1465-9921-6-68 16004610
142. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. H Chen MJ Cowan JD Hasday SN Vogel AE Medvedev, J Immunol 2007 179 9 6097 6106 17947684
143. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. RE MacRedmond CM Greene DR Dorscheid NG McElvaney SJ O'Neill, Respir Res 2007 8 84 10.1186/1465-9921-8-84 18034897
144. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. MJ Kang CG Lee JY Lee CS Dela Cruz ZJ Chen R Enelow JA Elias, J Clin Invest 2008 118 8 2771 2784 18654661
145. Cigarette smoke impacts immune inflammatory responses to influenza in mice. CS Robbins CM Bauer N Vujicic GJ Gaschler BD Lichty EG Brown MR Stampfli, Am J Respir Crit Care Med 2006 174 12 1342 1351 10.1164/rccm.200604-561OC 17023734
146. Defective macrophage phagocytosis of bacteria in COPD. AE Taylor TK Finney-Hayward JK Quint CM Thomas SJ Tudhope JA Wedzicha PJ Barnes LE Donnelly, Eur Respir J 2010 35 5 1039 1047 10.1183/09031936.00036709 19897561
147. Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. CS Berenson CT Wrona LJ Grove J Maloney MA Garlipp PK Wallace CC Stewart S Sethi, Am J Respir Crit Care Med 2006 174 1 31 40 10.1164/rccm.200509-1461OC 16574934
148. Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease. D Bogaert P van der Valk R Ramdin M Sluijter E Monninkhof R Hendrix R de Groot PW Hermans, Infect Immun 2004 72 2 818 823 10.1128/IAI.72.2.818-823.2004 14742525
149. Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. KH Groenewegen EF Wouters, Respir Med 2003 97 7 770 777 10.1016/S0954-6111(03)00026-X 12854626
150. Viral etiology of acute exacerbations of COPD in Hong Kong. FW Ko M Ip PK Chan MC Chan KW To SS Ng SS Chau JW Tang DS Hui, Chest 2007 132 3 900 908 10.1378/chest.07-0530 17573516
151. Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease. S Nseir B Cavestri C Di Pompeo M Diarra H Brisson M Lemyze M Roussel-Delvallez A Durocher, Respiration 2008 76 3 253 260 10.1159/000139611 18547944
152. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. S Sethi N Evans BJ Grant TF Murphy, N Engl J Med 2002 347 7 465 471 10.1056/NEJMoa012561 12181400 (Pubitemid 34879333)
153. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. AM Berry JE Alexander TJ Mitchell PW Andrew D Hansman JC Paton, Infect Immun 1995 63 5 1969 1974 7729909
154. Contribution of autolysin to virulence of Streptococcus pneumoniae. AM Berry RA Lock D Hansman JC Paton, Infect Immun 1989 57 8 2324 2330 2568343
155. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. JS Braun R Novak G Gao PJ Murray JL Shenep, Infect Immun 1999 67 8 3750 3756 10417133
156. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. R Cockeran C Durandt C Feldman TJ Mitchell R Anderson, J Infect Dis 2002 186 4 562 565 10.1086/341563 12195386
157. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. S Houldsworth PW Andrew TJ Mitchell, Infect Immun 1994 62 4 1501 1503 8132361
158. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. R Malley P Henneke SC Morse MJ Cieslewicz M Lipsitch CM Thompson E Kurt-Jones JC Paton MR Wessels DT Golenbock, Proc Natl Acad Sci USA 2003 100 4 1966 1971 10.1073/pnas.0435928100 12569171
159. The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. A Srivastava P Henneke A Visintin SC Morse V Martin C Watkins JC Paton MR Wessels DT Golenbock R Malley, Infect Immun 2005 73 10 6479 6487 10.1128/IAI.73.10.6479-6487.2005 16177320
160. Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. J Branger S Knapp S Weijer JC Leemans JM Pater P Speelman S Florquin T van der Poll, Infect Immun 2004 72 2 788 794 10.1128/IAI.72.2.788-794.2004 14742522 (Pubitemid 38166657)
161. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. R Schwandner R Dziarski H Wesche M Rothe CJ Kirschning, J Biol Chem 1999 274 25 17406 17409 10.1074/jbc.274.25.17406 10364168
162. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. A Yoshimura E Lien RR Ingalls E Tuomanen R Dziarski D Golenbock, J Immunol 1999 163 1 1 5 10384090
163. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. S Knapp CW Wieland C van't Veer O Takeuchi S Akira S Florquin T van der Poll, J Immunol 2004 172 5 3132 3138 14978119
164. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. B Albiger S Dahlberg A Sandgren F Wartha K Beiter H Katsuragi S Akira S Normark B Henriques-Normark, Cell Microbiol 2007 9 3 633 644 10.1111/j.1462-5822.2006.00814.x 17004992
165. Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice. B Albiger A Sandgren H Katsuragi U Meyer-Hoffert K Beiter F Wartha M Hornef S Normark BH Normark, Cell Microbiol 2005 7 11 1603 1615 10.1111/j.1462-5822.2005.00578.x 16207247
166. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2. AQ Khan Q Chen ZQ Wu JC Paton CM Snapper, Infect Immun 2005 73 1 298 307 10.1128/IAI.73.1.298-307.2005 15618166
167. Modulation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection. F Xu D Droemann J Rupp H Shen X Wu T Goldmann S Hippenstiel P Zabel K Dalhoff, Am J Respir Cell Mol Biol 2008 39 5 522 529 10.1165/rcmb.2007-0328OC 18483419
168. COPD exacerbations. 2: aetiology. E Sapey RA Stockley, Thorax 2006 61 3 250 258 10.1136/thx.2005.041822 16517585
169. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. V Bandi MA Apicella E Mason TF Murphy A Siddiqi RL Atmar SB Greenberg, Am J Respir Crit Care Med 2001 164 11 2114 2119 11739144
170. Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. VK Rao GP Krasan DR Hendrixson S Dawid JW St Geme, FEMS Microbiol Rev 1999 23 2 99 129 10234841
171. The pathogenicity of Haemophilus influenzae. DC Turk, J Med Microbiol 1984 18 1 1 16 10.1099/00222615-18-1-1 6146721
172. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable haemophilus influenzae from the mouse lung. CW Wieland S Florquin NA Maris K Hoebe B Beutler K Takeda S Akira T van der Poll, J Immunol 2005 175 9 6042 6049 16237099
173. Toll-like receptor 3 is involved in airway epithelial cell response to nontypeable Haemophilus influenzae. F Teng V Slavik KE Duffy L San Mateo R Goldschmidt, Cell Immunol 2010 260 2 98 104 10.1016/j.cellimm.2009.09.008 19878930
174. Production of interleukin-4 and interferon-gamma by TCR-V beta-expressing T-cell subsets in allergen-sensitized mice. H Renz K Bradley EW Gelfand, Am J Respir Cell Mol Biol 1996 14 1 36 43 8534484
175. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. D Robinson Q Hamid A Bentley S Ying AB Kay SR Durham, J Allergy Clin Immunol 1993 92 2 313 324 10.1016/0091-6749(93) 90175-F 8349942
176. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. MK Tulic RJ Hurrelbrink CM Prele IA Laing JW Upham P Le Souef PD Sly PG Holt, J Immunol 2007 179 1 132 140 17579031
177. Toll-like receptors and chronic lung disease. N Chaudhuri SK Dower MK Whyte I Sabroe, Clin Sci (Lond) 2005 109 2 125 133 10.1042/CS20050044 16033327
178. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. SC Eisenbarth DA Piggott JW Huleatt I Visintin CA Herrick K Bottomly, J Exp Med 2002 196 12 1645 1651 10.1084/jem.20021340 12486107
179. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. KJ Erb JW Holloway A Sobeck H Moll G Le Gros, J Exp Med 1998 187 4 561 569 10.1084/jem.187.4.561 9463406 (Pubitemid 28093358)
180. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. D Broide J Schwarze H Tighe T Gifford MD Nguyen S Malek J Van Uden E Martin-Orozco EW Gelfand E Raz, J Immunol 1998 161 12 7054 7062 9862743
181. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. JN Kline TJ Waldschmidt TR Businga JE Lemish JV Weinstock PS Thorne AM Krieg, J Immunol 1998 160 6 2555 2559 9510150
182. Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. ML Conrad R Ferstl R Teich S Brand N Blumer AO Yildirim CC Patrascan A Hanuszkiewicz S Akira H Wagner O Holst E von Mutius PI Pfefferle CJ Kirschning H Garn H Renz, J Exp Med 2009 206 13 2869 2877 10.1084/jem.20090845 19995952
183. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. H Hammad M Chieppa F Perros MA Willart RN Germain BN Lambrecht, Nat Med 2009 15 4 410 416 10.1038/nm.1946 19330007
184. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. D Yang Q Chen SB Su P Zhang K Kurosaka RR Caspi SM Michalek HF Rosenberg N Zhang JJ Oppenheim, J Exp Med 2008 205 1 79 90 10.1084/jem.20062027 18195069
185. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. CL Sokol NQ Chu S Yu SA Nish TM Laufer R Medzhitov, Nat Immunol 2009 10 7 713 720 10.1038/ni.1738 19465907
186. Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. S Moller-Larsen M Nyegaard A Haagerup J Vestbo TA Kruse AD Borglum, Thorax 2008 63 12 1064 1069 10.1136/thx.2007.094128 18682521
187. Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. P Camateros M Tamaoka M Hassan R Marino J Moisan D Marion MC Guiot JG Martin D Radzioch, Am J Respir Crit Care Med 2007 175 12 1241 1249 10.1164/rccm.200701-054OC 17400732
188. TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. J Moisan P Camateros T Thuraisingam D Marion H Koohsari P Martin ML Boghdady A Ding M Gaestel MC Guiot JG Martin D Radzioch, Am J Physiol Lung Cell Mol Physiol 2006 290 5 987 995 10.1152/ajplung.00440.2005 16361354
189. TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples. R Lazarus BA Raby C Lange EK Silverman DJ Kwiatkowski D Vercelli WJ Klimecki FD Martinez ST Weiss, Am J Respir Crit Care Med 2004 170 6 594 600 10.1164/rccm.200404-491OC 15201134
190. A multi-centre study of candidate genes for wheeze and allergy: the International Study of Asthma and Allergies in Childhood Phase 2. J Genuneit JL Cantelmo G Weinmayr GW Wong PJ Cooper MA Riikjarv M Gotua M Kabesch E von Mutius F Forastiere J Crane W Nystad N El-Sharif J Batlles-Garrido L Garcia-Marcos G Garcia-Hernandez M Morales-Suarez-Varela L Nilsson L Braback Y Saraclar SK Weiland WO Cookson D Strachan MF Moffatt, Clin Exp Allergy 2009 39 12 1875 1888 10.1111/j.1365-2222.2009.03364.x 20085599
191. Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy. JN Kline AM Krieg, Drug News Perspect 2008 21 8 434 439 19034349
192. Respiratory infections and asthma. G Pelaia A Vatrella L Gallelli T Renda M Cazzola R Maselli SA Marsico, Respir Med 2006 100 5 775 784 10.1016/j.rmed.2005.08.025 16289785
193. Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. L Allegra F Blasi S Centanni R Cosentini F Denti R Raccanelli P Tarsia V Valenti, Eur Respir J 1994 7 12 2165 2168 10.1183/09031936.94.07122165 7713198
194. Mycoplasma pneumoniae and asthma in children. S Biscardi M Lorrot E Marc F Moulin B Boutonnat-Faucher C Heilbronner JL Iniguez M Chaussain E Nicand J Raymond D Gendrel, Clin Infect Dis 2004 38 10 1341 1346 10.1086/392498 15156467
195. MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia. Y Naiki KS Michelsen NW Schroder R Alsabeh A Slepenkin W Zhang S Chen B Wei Y Bulut MH Wong EM Peterson M Arditi, J Biol Chem 2005 280 32 29242 29249 10.1074/jbc.M503225200 15964841
196. Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae. N Rodriguez N Wantia F Fend S Durr H Wagner T Miethke, Eur J Immunol 2006 36 5 1145 1155 10.1002/eji.200535152 16609927
197. TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. HW Chu S Jeyaseelan JG Rino DR Voelker RB Wexler K Campbell RJ Harbeck RJ Martin, J Immunol 2005 174 9 5713 5719 15843573
198. Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma. M Kraft KB Adler JL Ingram AL Crews TP Atkinson CB Cairns DC Krause HW Chu, Eur Respir J 2008 31 1 43 46 10.1183/09031936.00103307 18166592
199. Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance. Q Wu RJ Martin S Lafasto BJ Efaw JG Rino RJ Harbeck HW Chu, Am J Respir Crit Care Med 2008 177 7 720 729 10.1164/rccm.200709-1387OC 18202345
200. Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. P Andersen, Thorax 1998 53 4 302 307 10.1136/thx.53.4.302 9741376
201. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. M Kraft GH Cassell J Pak RJ Martin, Chest 2002 121 6 1782 1788 10.1378/chest.121.6.1782 12065339
202. The association between respiratory syncytial virus infection and reactive airway disease. G Piedimonte, Respir Med 2002 96 Suppl B 25 29 10.1053/rmed.2002.1297 11996401
203. Viruses in asthma exacerbations. WC Tan, Curr Opin Pulm Med 2005 11 1 21 26 15591884
204. Respiratory syncytial virus and parainfluenza virus. CB Hall, N Engl J Med 2001 344 25 1917 1928 10.1056/NEJM200106213442507 11419430
205. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. LM Haynes DD Moore EA Kurt-Jones RW Finberg LJ Anderson RA Tripp, J Virol 2001 75 22 10730 10737 10.1128/JVI.75.22.10730-10737.2001 11602714
206. Mortality associated with influenza and respiratory syncytial virus in the United States. WW Thompson DK Shay E Weintraub L Brammer N Cox LJ Anderson K Fukuda, JAMA 2003 289 2 179 186 10.1001/jama.289.2.179 12517228 (Pubitemid 36068705)
207. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. L Bont CJ Heijnen A Kavelaars WM van Aalderen F Brus JT Draaisma SM Geelen JL Kimpen, Am J Respir Crit Care Med 2000 161 5 1518 1523 10806148
208. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. DR Ehlenfield K Cameron RC Welliver, Pediatrics 2000 105 1 Pt 1 79 83 10.1542/peds.105.1.79 10617708
209. Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis. PM Renzi JP Turgeon JP Yang SP Drblik JE Marcotte L Pedneault S Spier, J Pediatr 1997 130 4 584 593 10.1016/S0022-3476(97)70243-9 9108857
210. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. M Roman WJ Calhoun KL Hinton LF Avendano V Simon AM Escobar A Gaggero PV Diaz, Am J Respir Crit Care Med 1997 156 1 190 195 9230746
211. A cohort of children hospitalised with acute RSV bronchiolitis: impact on later respiratory disease. N Sigurs, Paediatr Respir Rev 2002 3 3 177 183 10.1016/S1526-0542(02)00191-4 12376053
212. Human and bovine respiratory syncytial virus vaccine research and development. G Meyer M Deplanche F Schelcher, Comp Immunol Microbiol Infect Dis 2008 31 2-3 191 225 10.1016/j.cimid.2007.07.008 17720245
213. Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway. XH Xie HK Law LJ Wang X Li XQ Yang EM Liu, Pediatr Res 2009 65 2 156 162 10.1203/PDR.0b013e318191f5c6 18948841
214. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. EA Kurt-Jones L Popova L Kwinn LM Haynes LP Jones RA Tripp EE Walsh MW Freeman DT Golenbock LJ Anderson RW Finberg, Nat Immunol 2000 1 5 398 401 10.1038/80833 11062499
215. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. HA Haeberle R Takizawa A Casola AR Brasier HJ Dieterich N Van Rooijen Z Gatalica RP Garofalo, J Infect Dis 2002 186 9 1199 1206 10.1086/344644 12402188
216. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. AA Awomoyi P Rallabhandi TI Pollin E Lorenz MB Sztein MS Boukhvalova VG Hemming JC Blanco SN Vogel, J Immunol 2007 179 5 3171 3177 17709532
217. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. MR Murawski GN Bowen AM Cerny LJ Anderson LM Haynes RA Tripp EA Kurt-Jones RW Finberg, J Virol 2009 83 3 1492 1500 10.1128/JVI.00671-08 19019963
218. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. BD Rudd E Burstein CS Duckett X Li NW Lukacs, J Virol 2005 79 6 3350 3357 10.1128/JVI.79.6.3350-3357.2005 15731229
219. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. BD Rudd JJ Smit RA Flavell L Alexopoulou MA Schaller A Gruber AA Berlin NW Lukacs, J Immunol 2006 176 3 1937 1942 16424225
220. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. P Liu M Jamaluddin K Li RP Garofalo A Casola AR Brasier, J Virol 2007 81 3 1401 1411 10.1128/JVI.01740-06 17108032